UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium

HPB Surgery, 2015, Vol.2015, p.28-33

2015

Volltextzugriff (PDF)

Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial

Annals of surgery open, 2024-03, Vol.5 (1), p.e367-e367

2024

Volltextzugriff (PDF)

Long-Term Follow-Up of Patients with Advanced Colorectal Liver Metastasis: A Survival Analysis from the Randomized Controlled Multicenter Trial LIGRO

Annals of surgery open, 2024-09, Vol.5 (3), p.e455-e455

2024

Volltextzugriff (PDF)

Abstract 6519: Patient, primary colorectal tumor and liver metastases factors which influence survival after liver metastasectomy and therefore should be considered at the preoperative tumor board

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6519-6519

2020

Volltextzugriff (PDF)

Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9532-9532

2024

Volltextzugriff (PDF)

Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9533-9533

2024

Volltextzugriff (PDF)

A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial)

JOURNAL OF CLINICAL ONCOLOGY, 2023, Vol.41 (16_suppl), p.9533-9533

2023

Volltextzugriff (PDF)

Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial)

JOURNAL OF CLINICAL ONCOLOGY, 2023, Vol.41 (17_suppl), p.LBA9512-LBA9512

2023

Volltextzugriff (PDF)

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial)

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (17_suppl), p.LBA9509-LBA9509

2022

Volltextzugriff (PDF)

Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion

Journal of gastrointestinal surgery, 2019-03, Vol.23 (3), p.556-562

2019

Volltextzugriff (PDF)

ALPPS improves survival compared with TSH in patients affected of CRLM – Survival analysis from the randomized controlled trial LIGRO

International journal of surgery (London, England), 2020-03, Vol.75, p.S1-S1

2020

Volltextzugriff (PDF)

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma

Journal of visualized experiments, 2015-01 (95), p.52490-52490

2015

Volltextzugriff (PDF)

Selection criteria decisive in hepatocellular carcinoma

Läkartidningen, 2012-09, Vol.109 (39-40), p.1750-1753

2012

Volltextzugriff (PDF)

Autoradiography of a resected hepatocellular carcinoma treated with 90Y radioembolization illustrates uptake differences between viable and infarcted areas

European Journal of Nuclear Medicine and Molecular Imaging. 44 (Supplement 2), s. 802 (EP-0871), 2017

2017

Volltextzugriff (PDF)

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Journal of visualized experiments, 2015-01 (95)

2015

Volltextzugriff (PDF)

Simulation of 90Y microspheres in selective internal radiation therapy (SIRT) reveals different heterogeneity profiles for glass and resin microspheres

European Journal of Nuclear Medicine and Molecular Imaging. 43 (Suppl 1): 1, 2016

2016

Volltextzugriff (PDF)

Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

Trials, 2015-08, Vol.16 (1), p.334-334, Article 334

2015

Volltextzugriff (PDF)

Correction: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial (vol 15, 317, 2014)

Trials, 2015, Vol.16 (334)

2015

Volltextzugriff (PDF)

Radiation exposure during liver surgery after treatment with 90 Y microspheres, evaluated with computer simulations and dosimeter measurements

Journal of radiological protection, 2012-12, Vol.32 (4), p.439-446

2012

Volltextzugriff (PDF)

Radiation exposure during liver surgery after treatment with 90Y microspheres, evaluated with computer simulations and dosimeter measurements

Journal of radiological protection, 2012-10, Vol.32 (4), p.439-446

2012

Volltextzugriff (PDF)

Radiation exposure during liver surgery after treatment with (90)Y microspheres, evaluated with computer simulations and dosimeter measurements

Journal of radiological protection, 2012, Vol.32 (4), p.439-446

2012

Volltextzugriff (PDF)

Development and Psychometric Evaluation of the Instrument: Attitudes Towards Organ Donor Advocacy Scale (ATODAS)

The open nursing journal, 2011, Vol.5, p.65-73

2011

Volltextzugriff (PDF)

Living donor kidney transplantation--a successful story. Very cost-effective--and the donors live long with good health

Läkartidningen, 2011-11, Vol.108 (48), p.2492-2495

2011

Volltextzugriff (PDF)

Living donor kidney transplantation--a successful story. Very cost-effective--and the donors live long with good health: Transplantation av njure från levande givare--en framgångssaga. Mycket kostnadseffektivt--och givarna lever friska länge

Läkartidningen, 2011, Vol.108 (48), p.2492

2011

Volltextzugriff (PDF)

Kidney transplantation--a 46-year experience from the Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden

Clinical transplants, 2011, p.119

2011

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of Surgery

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(28)
Schwedisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(9)
Adult
(6)
Female
(6)
Medicin Och Hälsovetenskap
(6)
Middle Aged
(6)
Kirurgi
(5)
Male
(5)
Radiologi Och Bildbehandling
(5)
Radiology, Nuclear Medicine And Medical Imaging
(5)
Surgery
(5)
Sweden
(5)
Treatment Outcome
(4)
Cancer And Oncology
(3)
Cancer Och Onkologi
(3)
Child
(3)
Liver Neoplasms - Surgery
(3)
Attitude Of Health Personnel
(2)
Care And Treatment
(2)
Cost-Benefit Analysis
(2)
Glomerular Filtration Rate
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium

Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial

Long-Term Follow-Up of Patients with Advanced Colorectal Liver Metastasis: A Survival Analysis from the Randomized Controlled Multicenter Trial LIGRO

Abstract 6519: Patient, primary colorectal tumor and liver metastases factors which influence survival after liver metastasectomy and therefore should be considered at the preoperative tumor board

Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)

Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial)

A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial)

Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial)

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial)

Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion

ALPPS improves survival compared with TSH in patients affected of CRLM – Survival analysis from the randomized controlled trial LIGRO

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma

Selection criteria decisive in hepatocellular carcinoma

Autoradiography of a resected hepatocellular carcinoma treated with 90Y radioembolization illustrates uptake differences between viable and infarcted areas

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Simulation of 90Y microspheres in selective internal radiation therapy (SIRT) reveals different heterogeneity profiles for glass and resin microspheres

Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

Correction: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial (vol 15, 317, 2014)

Radiation exposure during liver surgery after treatment with 90 Y microspheres, evaluated with computer simulations and dosimeter measurements

Radiation exposure during liver surgery after treatment with 90Y microspheres, evaluated with computer simulations and dosimeter measurements

Radiation exposure during liver surgery after treatment with (90)Y microspheres, evaluated with computer simulations and dosimeter measurements

Development and Psychometric Evaluation of the Instrument: Attitudes Towards Organ Donor Advocacy Scale (ATODAS)

Living donor kidney transplantation--a successful story. Very cost-effective--and the donors live long with good health

Living donor kidney transplantation--a successful story. Very cost-effective--and the donors live long with good health: Transplantation av njure från levande givare--en framgångssaga. Mycket kostnadseffektivt--och givarna lever friska länge

Kidney transplantation--a 46-year experience from the Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden

Aktive Filter

Suchergebnisse filtern